SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $156,000 | -13.3% | 2,083 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $180,000 | -71.7% | 2,083 | -53.7% | 0.00% | -71.4% |
Q3 2018 | $636,000 | +31.4% | 4,500 | +49.9% | 0.01% | +16.7% |
Q1 2018 | $484,000 | -2.0% | 3,002 | 0.0% | 0.01% | +9.1% |
Q4 2017 | $494,000 | -41.4% | 3,002 | -77.8% | 0.01% | -42.1% |
Q3 2017 | $843,000 | -21.7% | 13,528 | 0.0% | 0.02% | -20.8% |
Q2 2017 | $1,077,000 | +12.1% | 13,528 | 0.0% | 0.02% | +14.3% |
Q1 2017 | $961,000 | +39.1% | 13,528 | 0.0% | 0.02% | +40.0% |
Q4 2016 | $691,000 | +10.9% | 13,528 | 0.0% | 0.02% | +7.1% |
Q3 2016 | $623,000 | – | 13,528 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |